Author Page for Alvina Chu

Actions:

View:
Selected
Original List
All Versions Hide All Versions
All Abstracts Hide All Abstracts

(Rank)

Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Pivotal Phase 3, Randomised, Double-Blind, Placebo-Controlled Study (AD Up)

Number of pages: 54 Posted: 09 Apr 2021

Kristian Reich, Henrique D. Teixeira, Marjolein de Bruin-Weller, Thomas Bieber, Weily Soong, Kenji Kabashima, Thomas Werfel, Jiewei Zeng, Xiaohong Huang, Xiaofei Hu, Barbara Hendrickson, Barry Ladizinski, Alvina Chu and Jonathan Silverberg

University of Hamburg - Translational Research in Inflammatory Skin Diseases, AbbVie Inc., University Medical Centre Utrecht - National Expertise Center of Atopic Dermatitis, University Hospital of Bonn - Department of Dermatology and Allergy, Clinical Research Center of Alabama, Kyoto University Graduate School of Medicine - Department of Dermatology, Hannover Medical School - Division of Immunodermatology and Allergy Research,, AbbVie Inc., AbbVie Inc., AbbVie Inc., AbbVie Inc., AbbVie Inc., AbbVie Inc. and George Washington University School of Medicine and Health Sciences - Department of Dermatology

Downloads 182 (418,025)

Citation 2

Alvina Chu

AbbVie Inc.

1

182

2

Scholarly Papers (1)

Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Pivotal Phase 3, Randomised, Double-Blind, Placebo-Controlled Study (AD Up)

Abstract: